Unlike classic T1DM, where the presence of autoantibodies is a reliable predictor of immune tolerance and clinical manifestation, anti-IA2 usually precedes the clinical onset of T1DM due to autoimmunity and remains the best predictor of immune tolerance and clinical manifestation of T1DM. Here, PTPRN is linked to Autoimmunity.